AzTrials
AzTrials

Postoperative PainPhase 4METATONSNCT05445856

Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy

A Phase 4 study testing Methadone and Fentanyl in people with Postoperative Pain, run by University of Aarhus at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Postoperative Pain
What is being tested?
Methadone and Fentanyl
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteDenmark
Study dates
28 Nov 2022to Aug 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All patients (≥18 years) scheduled for elective tonsillectomy

Who cannot join

  • American Society of Anaesthesiologists (ASA) physical status IV or V
  • Allergy to study drugs
  • Daily use of opioids 7 days prior to surgery
  • Inability to provide informed consent
  • Severe respiratory insufficiency
  • Heart failure
Show all 15Show fewer
  • Acute alcohol intoxication/delirium tremens
  • Increased intracranial pressure
  • Acute liver disease
  • Liver insufficiency
  • Kidney insufficiency
  • Treatment with rifampicin
  • Treatment with any drug prolonging the QT-interval
  • Pregnancy (every female not using contraceptives will be screened with urine human choriogonadotropin)
  • Breastfeeding

Trial locations and contacts

1 site in 1 country.

Michael Bøndergaard, MD contact

004578420510

michael.vinther@gmail.com

Kristian Friesgaard, MD, PhD contact

00457842332

k.friesgaard@me.com

Denmark1 site, 1 recruiting
  • Department of Anaesthesiology and Intensive Care

    Randers

    Michael Bøndergaard, MD, 51326539, michael.vinther@gmail.com

    Recruiting

Other trials in Denmark

About this study

Official title: Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy - a Randomized Controlled Trial

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

Read the detailed description

This study is an investigator-initiated, prospective, randomised controlled trial with two arms: an intervention arm (methadone) and a control arm (fentanyl). Patients scheduled for tonsillectomy at Randers Regional Hospital, Denmark, will be approached for study participation.

Patients are randomised in a 1:1 ratio in blocks of varying sizes (between 4 and 8) to receive either intraoperative methadone or fentanyl. The randomisation assignment will be handled by the hospital pharmacy using a web-based central randomisation procedure (www.sealedenvelope.com).

The study drug will be prepared by the hospital pharmacy at Aarhus University Hospital and delivered as kits with identical appearance, marked with the randomization number (1-130). On the day of surgery, a kit will be opened and a 10 ml syringe with study drug (methadone 2 mg/ml or fentanyl 30 microgram/ml or ) will prepared by a health care professional (nurse or medical doctor not involved in the study or the treatment of patients). Once prepared, the blinded study drug will be given to and handled by one of the research team members and administered after induction of anesthesia and prior to surgery

The dose of the study drug will be administered as intravenous bolus dose in equipotent doses (0.2 mg/kg / 3 μg/kg) corresponding to 1 ml for every 10 kg of ideal body weight (women: height (cm) - 105. Men: height (cm) - 100)) after induction of anaesthesia and before the start of surgery.

Postoperative data will be obtained by reviewing hospital records, by interview and electronic questionnaires sent by email.

Being tested
Methadone, Fentanyl
Keywords
Postoperative pain, Methadone
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MethadoneDrug

    Methadone is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

  • FentanylDrug

    Fentanyl is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

Study groups in NCT05445856
Study groupRoleWhat they receive
MethadoneExperimentalSingle-shot intravenous methadone 0.2 mg/kg administered intraoperatively
Receives: Drug: Methadone
FentanylActive comparatorSingle-shot intravenous fentanyl 3 microgram/kg administered intraoperatively
Receives: Drug: Fentanyl

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

    Measured: On arrival at the post-anesthesia care unit

  2. Opioid consumption

    Cumulative postoperative opioid consumption in morphine equivalents

    Measured: First 5 postoperative days

Secondary outcomes (4)
  1. Postoperative pain

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

    Measured: 1, 2, 3, 5 and 7 days after surgery

  2. Opioid consumption

    Cumulative postoperative opioid consumption in morphine equivalents

    Measured: 1 and 7 days after surgery

  3. Postoperative nausea and vomiting (none, mild, moderate, severe)

    Nausea and/or vomiting (PONV), proportion of patients with none or mild PONV

    Measured: 1, 2 and 3 days after surgery

  4. Sedation

    Level of sedation (Ramsay Scale (1-4)), proportion of patients being co-operative, oriented and tranquil

    Measured: 4 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2022
  2. Study start28 Nov 2022
  3. Primary completionJan 2024 (estimated)
  4. Study completionAug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05445856
Sponsor's protocol ID
2022-002496-11
Acronym
METATONS
Status last verified
Dec 2023
First submitted
30 Jun 2022
Last updated
5 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: IPD will be shared upon reasonable request

Publications

  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Posterior Spinal Fusion Surgery: A Randomized, Double-blinded, Controlled Trial. Anesthesiology. 2017 May;126(5):822-833. doi: 10.1097/ALN.0000000000001609.

    PubMed 28418966
  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, Parikh KN, Patel SS, Gupta DK. Intraoperative Methadone for the Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial in Cardiac Surgical Patients. Anesthesiology. 2015 May;122(5):1112-22. doi: 10.1097/ALN.0000000000000633.

    PubMed 25837528
  • Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.

    PubMed 20418538
  • Udelsmann A, Maciel FG, Servian DC, Reis E, de Azevedo TM, Melo Mde S. Methadone and morphine during anesthesia induction for cardiac surgery. Repercussion in postoperative analgesia and prevalence of nausea and vomiting. Rev Bras Anestesiol. 2011 Nov-Dec;61(6):695-701. doi: 10.1016/S0034-7094(11)70078-2. English, Multiple languages.

    PubMed 22063370
  • Bondergaard M, Uhrbrand PG, Karaca T, Rhode M, Kjaergaard T, Svendsen RT, Klug TE, Nikolajsen L, Friesgaard KD. Intraoperative methadone for postoperative pain in adult patients undergoing tonsillectomy-a randomised controlled trial. BJA Open. 2025 May 26;14:100418. doi: 10.1016/j.bjao.2025.100418. eCollection 2025 Jun.

    PubMed 40502985

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Methadone and Fentanyl in people with Postoperative Pain, run by University of Aarhus at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michael Bøndergaard, MD (004578420510, michael.vinther@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain (time frame: On arrival at the post-anesthesia care unit). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05445856, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in